Systemic Embolism and Clinically Significant Bleeding Events in Older Adults with Nonvalvular Atrial Fibrillation After Treatment with Direct Oral Anticoagulants and Warfarin: A Retrospective Cohort Study in Japan
Daichi Yaguchi, Shoji Sera, Akira Okada, Yuki Nishimura, Satoshi Tamaru, Naomi Nagai, Valeria Conti · 2024
Read Systemic Embolism and Clinically Significant Bleeding Events in Older Adults with Nonvalvular Atrial Fibrillation After Treatment with Direct Oral Anticoagulants and Warfarin: A Retrospective Cohort Study in Japan by Daichi Yaguchi, Shoji Sera, Akira Okada, Yuki Nishimura, Satoshi Tamaru, Naomi Nagai, Valeria Conti (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11676222.txt.
Description
Daichi Yaguchi and co-authors compare modern blood thinners with warfarin in older Japanese patients with atrial fibrillation, in a 2024 study. The irregular heartbeat raises stroke risk, so anticoagulants are standard, but they also raise bleeding risk, a delicate balance after age seventy-five. The team drew on a regional medical database covering nearly eighteen hundred patients.
Most patients took one of the newer direct oral anticoagulants, split among four drugs, while the rest stayed on warfarin. Serious bleeding accumulated at similar rates in both groups. Clot events traveling through the body, though, differed significantly, with one of the newer drugs standing out in the comparison. Real-world evidence like this matters because trial populations are usually younger and healthier than the patients who fill clinics.
Catalog record
| CREATOR | Daichi Yaguchi, Shoji Sera, Akira Okada, Yuki Nishimura, Satoshi Tamaru, Naomi Nagai, Valeria Conti |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |